BRAF and neoplasm: We then tested combinational drug treatment, using the BRAF inhibitors to target the bulk of the tumor and NAZ to target ALDH1High cells: (1) BRAFi followed by NAZ (BRAFi_NAZ) at day 21, and (2) BRAFi treatment alone until day 21, followed by both BRAFi + NAZ (Figure 7G).